Analysts await Ardelyx, Inc. (NASDAQ:ARDX) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $-0.65 EPS, down 70.77% or $0.46 from last year’s $-0.19 per share.

At the moment 7 analysts are watching Ardelyx, Inc. (NASDAQ:ARDX), 5 rate it “Buy”, 2 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 6 analysts have a mean sales target of 0.00 million. For the quarter ending Sep-16, 6 analysts have a mean sales target of 0.00 million whilst for the year ending Dec-16, 5 analysts have a mean target of 0.00 million.

In terms of earnings per share, 7 analysts have a -0.68 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 7 analysts have a -0.75 EPS mean target and for the quarter ending Sep-16 there are 7 estimates of -2.93 EPS.

The biggest institutional shareholders in Ardelyx, Inc. include NEA Management Company, LLC which owns 10 million shares in the company valued at $186.53 million. Fidelity Management and Research Company is the second biggest holder with 3 million shares currently valued at 59.87 million whilst Presidio Partners has 3 million shares valued at 46.02 million.

Total shares held by institutions as of the most recent company filings are 23,787,321 with a reported 1,985,507 bought and 1,247,951 sold. These holdings make up 68.7% of the company’s outstanding shares.

Currently insiders hold 1,084,971 shares in the business which makes up 3.13% of shares. The biggest holder currently is Peter G. Schultz,PhD who owns 910,339 shares (2.63% of those outstanding), whilst Mr. Paul Korner holds 60,753 (0.18% of shares outstanding) and Dr. Jeffrey Jacobs holds 47,420 (0.14% of shares outstanding).

The stock decreased 4.84% or $0.37 during the last trading session, hitting $46.82. Ardelyx, Inc. (NASDAQ:ARDX) has risen 59.16% over the past 6 months and is uptrending.